Recent developments on Junin virus, a causative agent for Argentine haemorrhagic fever

Rev Med Virol. 2023 Mar;33(2):e2419. doi: 10.1002/rmv.2419. Epub 2023 Jan 12.

Abstract

Junin virus consists of ribonucleic acid as the genome and is responsible for a rapidly changing tendency of the virus. The virus is accountable for ailments in the human body and causes Argentine Haemorrhagic Fever (AHF). The infection is may be transmitted through contact between an infected animal/host and a person, and later between person to person. Prevention of outbreaks of AHF in humans can be a tough practice, as their occurrence is infrequent and unpredictable. In this review, recent information from the past 5 years available on the Junin virus including the risk of its emergence, infectious agents, its pathogenesis in humans, available diagnostic and therapeutic approaches, and disease management has been summarised. Altogether, this article would be highly significant in understanding the mechanistic basis behind virus interaction and other processes during the life cycle. Currently, no specific therapeutic options are available to treat the Junin virus infection. The information covered in this review could be important for finding possible treatment options for Junin virus infections.

Keywords: Argentine haemorrhagic fever (AHF); Junin virus; plasma therapy; rodent.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Hemorrhagic Fever, American* / diagnosis
  • Hemorrhagic Fever, American* / pathology
  • Humans
  • Junin virus* / genetics